Literature DB >> 15033850

Cardiac complications of enterovirus rhombencephalitis.

Y C Fu1, C S Chi, Y T Chiu, S L Hsu, B Hwang, S L Jan, P Y Chen, F L Huang, Y Chang.   

Abstract

BACKGROUND: Epidemics of enterovirus 71 infection have caused the death of many children throughout the world. Rhombencephalitis, brain stem encephalitis, and heart failure were present in all of the fatal cases. However, no evidence of myocarditis was noted in the heart specimens, and the mechanism of heart failure remains unknown. AIMS: To characterise the presentation of cardiac complications in children with enterovirus rhombencephalitis and discuss its pathogenesis.
METHODS: Ninety one consecutive patients with enterovirus rhombencephalitis underwent echocardiography. Of these, 17 patients (nine male, eight female; median age 14 months, range 4-57 months) with left ventricular dysfunction were studied.
RESULTS: Tachycardia was noted in all patients and systemic hypertension in 12. Muscle-brain fraction of creatine kinase was >5% in 14 patients. Plasma norepinephrine and epinephrine levels were significantly raised in the three patients in whom these were analysed. Electrocardiographic abnormalities were noted in eight patients. Pulmonary oedema was complicated in 15 patients. The initial ejection fraction of the left ventricle was 22-58% (mean 37%, SD 11%). All patients deteriorated to hypotensive shock within 12 hours and 13 died. Heart specimens from seven patients showed no evidence of myocarditis, but significant coagulative myocytolysis, myofibrillar degeneration, and cardiomyocyte apoptosis were observed.
CONCLUSIONS: Acute heart failure was noted in 19% of patients with enterovirus rhombencephalitis, which had a fatality rate of 77%. It was not caused by myocarditis but possibly by neurogenic cardiac damage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15033850      PMCID: PMC1719879          DOI: 10.1136/adc.2003.029645

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  24 in total

1.  General primer-mediated polymerase chain reaction for detection of enteroviruses: application for diagnostic routine and persistent infections.

Authors:  G J Zoll; W J Melchers; H Kopecka; G Jambroes; H J van der Poel; J M Galama
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

2.  An apparently new enterovirus isolated from patients with disease of the central nervous system.

Authors:  N J Schmidt; E H Lennette; H H Ho
Journal:  J Infect Dis       Date:  1974-03       Impact factor: 5.226

3.  Virological diagnosis of enterovirus type 71 infections: experiences gained during an epidemic of acute CNS diseases in Hungary in 1978.

Authors:  G Nagy; S Takátsy; E Kukán; I Mihály; I Dömök
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

4.  Epidemiological, clinical, and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71.

Authors:  L M Shindarov; M P Chumakov; M K Voroshilova; S Bojinov; S M Vasilenko; I Iordanov; I D Kirov; E Kamenov; E V Leshchinskaya; G Mitov; I A Robinson; S Sivchev; S Staikov
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1979

5.  Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group.

Authors:  L G Chan; U D Parashar; M S Lye; F G Ong; S R Zaki; J P Alexander; K K Ho; L L Han; M A Pallansch; A B Suleiman; M Jegathesan; L J Anderson
Journal:  Clin Infect Dis       Date:  2000-10-04       Impact factor: 9.079

6.  Heart size on chest x-ray as a predictor of cardiac enlargement by echocardiography in children.

Authors:  G M Satou; R V Lacro; T Chung; K Gauvreau; K J Jenkins
Journal:  Pediatr Cardiol       Date:  2001 May-Jun       Impact factor: 1.655

7.  Heart damage associated with intracranial lesions.

Authors:  R C Connor
Journal:  Br Med J       Date:  1968-07-06

8.  Subarachnoid hemorrhage and the heart.

Authors:  D W Marion; R Segal; M E Thompson
Journal:  Neurosurgery       Date:  1986-01       Impact factor: 4.654

9.  Semiquantitative grading of severity of mitral regurgitation by real-time two-dimensional Doppler flow imaging technique.

Authors:  K Miyatake; S Izumi; M Okamoto; N Kinoshita; H Asonuma; H Nakagawa; K Yamamoto; M Takamiya; H Sakakibara; Y Nimura
Journal:  J Am Coll Cardiol       Date:  1986-01       Impact factor: 24.094

10.  Left ventricular wall motion abnormalities in subarachnoid hemorrhage: an echocardiographic study.

Authors:  C Pollick; B Cujec; S Parker; C Tator
Journal:  J Am Coll Cardiol       Date:  1988-09       Impact factor: 24.094

View more
  17 in total

1.  Comparison of heart failure in children with enterovirus 71 rhombencephalitis and cats with norepinephrine cardiotoxicity.

Authors:  Y-C Fu; C-S Chi; N-N Lin; C-C Cheng; S-L Jan; B Hwang; S-L Hsu; C-L Gong; Y-T Chen; Y-T Chiu
Journal:  Pediatr Cardiol       Date:  2006 Sep-Oct       Impact factor: 1.655

2.  [Clinical effect of carvedilol in treatment of children with severe hand-foot-mouth disease caused by enterovirus 71 infection].

Authors:  Xiao-Yan Gong; Bing-Fei Li
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2019-08

Review 3.  Recent advances in enterovirus A71 pathogenesis: a focus on fatal human enterovirus A71 infection.

Authors:  Jingjun Xing; Ke Wang; Geng Wang; Na Li; Yanru Zhang
Journal:  Arch Virol       Date:  2022-09-29       Impact factor: 2.685

Review 4.  Chinese guidelines for the diagnosis and treatment of hand, foot and mouth disease (2018 edition).

Authors:  Xing-Wang Li; Xin Ni; Su-Yun Qian; Quan Wang; Rong-Meng Jiang; Wen-Bo Xu; Yu-Cai Zhang; Guang-Jun Yu; Qiang Chen; Yun-Xiao Shang; Cheng-Song Zhao; Hui Yu; Ting Zhang; Gang Liu; Hui-Ling Deng; Jie Gao; Xian-Gui Ran; Qiao-Zhi Yang; Bian-Li Xu; Xue-Yong Huang; Xing-Dong Wu; Yi-Xiao Bao; Yi-Ping Chen; Zhi-Hai Chen; Qing-Quan Liu; Guo-Ping Lu; Chun-Feng Liu; Rong-Bing Wang; Guo-Liang Zhang; Fang Gu; Hong-Mei Xu; Ying Li; Tao Yang
Journal:  World J Pediatr       Date:  2018-10-03       Impact factor: 2.764

5.  Extracorporeal life support for treatment of children with enterovirus 71 infection-related cardiopulmonary failure.

Authors:  Sheng-Ling Jan; Shing-Jong Lin; Yun-Ching Fu; Ching-Shiang Chi; Chung-Chi Wang; Hao-Ji Wei; Yen Chang; Betau Hwang; Po-Yen Chen; Fang-Liang Huang; Ming-Chih Lin
Journal:  Intensive Care Med       Date:  2009-12-24       Impact factor: 17.440

6.  Intravenous magnesium sulfate for the management of severe hand, foot, and mouth disease with autonomic nervous system dysregulation in Vietnamese children: study protocol for a randomized controlled trial.

Authors:  Phan Tu Qui; Truong Huu Khanh; Huynh Trung Trieu; Phạm Thanh Giang; Nguyen Ngọc Bich; Le Phan Kim Thoa; Le Nguyen Thanh Nhan; Saraswathy Sabanathan; Rogier Van Doorn; Nguyen Duc Toan; Laura Merson; Nguyen Thi Phuong Dung; Lam Phung Khanh; Marcel Wolbers; Nguyen Thanh Hung; Nguyen Van Vinh Chau; Bridget Wills
Journal:  Trials       Date:  2016-02-19       Impact factor: 2.279

7.  Direct Identification of Enteroviruses in Cerebrospinal Fluid of Patients with Suspected Meningitis by Nested PCR Amplification.

Authors:  Alexandr Krasota; Natalia Loginovskih; Olga Ivanova; Galina Lipskaya
Journal:  Viruses       Date:  2016-01-06       Impact factor: 5.048

8.  Norepinephrine and Epinephrine Enhanced the Infectivity of Enterovirus 71.

Authors:  Yu-Ting Liao; Shih-Min Wang; Jen-Ren Wang; Chun-Keung Yu; Ching-Chuan Liu
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

9.  GABAB Encephalitis: A Fifty-Two-Year-Old Man with Seizures, Dysautonomia, and Acute Heart Failure.

Authors:  Matthew C Loftspring; Eric Landsness; Lindsey Wooliscroft; Robert Rudock; Sally Jo; Kevin R Patel
Journal:  Case Rep Neurol Med       Date:  2015-11-02

10.  Risk factors for death in children with critical and severe hand-foot-and-mouth disease in Chongqing, China: An observational study.

Authors:  Gaihuan Zheng; Jiaoyang Cao; Jie Yu; Zhenzhen Zhang; Quanbo Liu; Junhua Chen
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.